Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 292
Filter
1.
Epidemiol. serv. saúde ; 30(spe1): e2020593, 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1154147

ABSTRACT

O tema corrimento vaginal é um dos capítulos que compõem o Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis, publicado pelo Ministério da Saúde do Brasil em 2020. Tal documento foi elaborado com base em evidências científicas e validado em discussões com especialistas. Neste artigo, são apresentados aspectos epidemiológicos e clínicos relacionados às situações de corrimento vaginal, bem como orientações aos gestores e profissionais de saúde na triagem, diagnóstico e tratamento desses agravos, que constituem uma das principais queixas entre mulheres que procuram serviços de saúde e que podem ser causados por fatores infecciosos ou não infecciosos. Além disso, são apresentadas informações sobre estratégias para as ações de vigilância, prevenção e controle, a fim de promover o conhecimento do problema e a oferta de assistência de qualidade e tratamento efetivo.


The topic of vaginal discharge is one of the chapters of the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. The chapter has been developed based on scientific evidence and validated in discussions with specialists. This article presents epidemiological and clinical aspects related to vaginal discharge conditions, as well as guidelines for health service managers and health professionals about screening, diagnosing and treating these conditions, which are one of the main complaints among women seeking health services, and which may be caused by infectious or non-infectious factors. In addition, information is presented on strategies for surveillance, prevention and control actions, in order to promote knowledge of the problem and provision of quality care and effective treatment.


El tema del flujo vaginal es uno de los capítulos del Protocolo Clínico y Directrices Terapéuticas para la Atención Integral a las Personas con Infecciones de Transmisión Sexual, publicado por el Ministerio de Salud de Brasil en 2020. El documento fue desarrollado en base a evidencia científica y validado en discusiones con especialistas. En este artículo se presentan aspectos epidemiológicos y clínicos relacionados a las situaciones de flujo vaginal, así como pautas para gestores y profesionales de la salud en el cribado, diagnóstico y tratamiento de esas complicaciones, que son una de las principales quejas entre las mujeres que buscan servicios de salud y que pueden ser causadas por factores infecciosos o no infecciosos. Además, se presenta información sobre estrategias para acciones de vigilancia, prevención y control, con el fin de promover la comprensión del problema y la oferta de asistencia de calidad y tratamiento eficaz.


Subject(s)
Humans , Female , Vaginitis/epidemiology , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Quality of Health Care , Vaginitis/diagnosis , Brazil/epidemiology , Sexually Transmitted Diseases/prevention & control
3.
Femina ; 47(4): 235-240, 20190430.
Article in Portuguese | LILACS, SES-SP, SESSP-HMLMBACERVO, SESSP-HMLMBPROD, SES-SP | ID: biblio-1046513
4.
Rev. colomb. obstet. ginecol ; 70(1): 49-56, Jan-Mar. 2019. graf
Article in English | LILACS | ID: biblio-1042828

ABSTRACT

ABSTRACT Objective: To determine the prevalence of potentially pathogenic microbiological agents in vaginal exudates in a sample of asymptomatic pregnant women in the Department of Atlantico, Colombia. Materials and Methods: Descriptive cross-sectional study of a sample of asymptomatic pregnant women who attended a private primary healthcare institution in Barranquilla, Colombia, between 2014 and 2015. Pregnant women having received antimicrobial treatment within the last 30 days, with vaginal bleeding, mental disability or immunosuppression, were excluded. Consecutive sampling was performed. The prevalence of colonization time by some of the microbiological agents as well as specific prevalence were estimated: number of women with infection by agent type/number of women at risk assessed. Results: Overall prevalence was 24.8% (56/226); 55.4% (31/56) was due to vaginitis causal agents, and 44.6% (25/56) to vaginosis. The specific prevalence by type of pathogen, 13.3% (30/226) was vaginitis due to colonization by Candida spp. and 0.4% (1/226) was vaginitis due to T. vaginalis. Bacterial vaginosis (BV) was found in 8.0% (18/226). Conclusion: Substantial colonization of the lower genital tract by potentially pathogenic germs is found in pregnant women between 35 and 37 weeks of gestation. Further studies are required in order to determine the benefit of population screening in terms of avoiding poor maternal and perinatal outcomes, and the impact on the resulting overcosts.


RESUMEN Objetivo: establecer la prevalencia de agentes microbiológicos potencialmente patógenos en el exudado vaginal de gestantes asintomáticas del departamento del Atlántico, Colombia. Materiales y métodos: estudio de corte transversal descriptivo. Se incluyeron gestantes asintomáticas que acudieron a una institución privada de atención primaria en salud en Barranquilla, Colombia, en 2014 y 2015. Se excluyeron gestantes con tratamiento antimicrobiano en los últimos 30 días, sangrado genital, discapacidad mental e inmunosupresión. Se hizo un muestreo consecutivo no estricto. Se calculó la prevalencia de periodo de colonización por algunos de los agentes microbiológicos y la específica: número de mujeres con infección por tipo de agente/número de mujeres evaluadas en riesgo. Resultados: la prevalencia global fue de 24,8 % (56/226). De estas, el 55,4 % (31/56) fue debido a vaginitis y el 44,6 % (25/56) por vaginosis. La prevalencia específica según tipo de patógenos fue: vaginitis por Candida spp. en 13,3 % (30/226) y por T. vaginalis 0,4 % (1/226). La VB se presentó en 8,0 % (18/226) y una flora intermedia de 3,1 % (7/226). Conclusión: existe una importante colonización del tracto genital inferior de gérmenes potencialmente patógenos en mujeres gestantes de 35 a 37 semanas. Se requieren estudios adicionales para determinar el beneficio de la tamización poblacional en términos de malos resultados maternos perinatales evitados y costos.


Subject(s)
Female , Pregnancy , Bacterial Infections , Vaginitis , Vaginosis, Bacterial , Pregnant Women
5.
Infectio ; 22(2): 76-83, abr.-jun. 2018. tab
Article in English | LILACS, COLNAL | ID: biblio-892757

ABSTRACT

Abstract Vaginitis as female infectious disease is accompanied with some clinical symptoms such as vaginal abnormal discharges, itching, burning and many other unpleasant signs in patients. The responsible microorganisms in vaginitis are belonged to different kind of microorganisms including bacteria (Gardenella vaginitis), yeast (Candida albicans) and protozoa (Trichomonas vaginalis). The current treatments of these infections are chemical oral and vaginal drugs with many adverse effects for patients. Furthermore, appearance of resistant microorganisms to these drugs has intensified the treatment's problem. The aim of this review article was to evaluate the potency of "Zataria multiflora" essential oil in treatment of women's vaginitis. For preparing this manuscript, the information was extracted from different electronic and published resources. Investigation in different resources showed there were 6 clinical trials that evaluate it as suitable treatment for vaginitis. 5 clinical studies have been focused on 0.1% Z. multiflora essential oils in treatment of bacterial vaginosis (n=1), candidiasis (n=1) and trichomoniasis (n=1). Two clinical studies were related to treatments of bacterial vaginosis, trichomoniasis and mixed infection. There is one clinical study for treatment of candidiasis by 1% Z. multiflora methanol extract. Z. multiflora was formulated in cream form and applied for 5-7 continuous days. The results of clinical trials showed that Z. multiflora essential oil (0.1%) can be used as safe and efficient alternative treatment for treatment of bacterial vaginosis, candidiasis and to a lesser extent for trichomoniasis.


Resumen La vaginitis es una enfermedad infecciosa femenina acompañada de algunos síntomas como flujo vaginal, prurito, sensación de ardor y otros síntomas de incomodidad para las pacientes. Los microorganismos responsables de vaginitis son variados e incluyen bacterias (Gardenella vaginitis), hongos (Candida albicans) y protozoos (Trichomonas vaginalis). Los tratamientos utilizados actualmente son medicamentos de uso oral o vaginal con potenciales efectos adversos. Adicionalmente se encuentran organismos resistentes a estos tratamientos, lo que ha llevado a la búsqueda de nuevas alternativas. El propósito de esta revisión sistemática fue evaluar la potencia del aceite esencia de "Zataria multiflora" para el tratamientos de la vaginitis. Se realizó una búsqueda en recursos bibliográficos y bases de datos electrónicos. Se encontraron seis ensayos clínicos que evaluaron este aceite para el tratamiento de la vaginitis. En 5 estudios clínicos se utilizó aceite esencial al 0.1% de Z. multiflora para el tratamiento de vaginosis bacteriana (n=1), candidiasis (n=1) y tricomoniasis (n=1) y en tres estudios se usó para tratamiento tanto de infecciones bacterianas, tricomoniasisi o mixtas. Se encontró un estudio para tratamiento de la candidiasis con extracto en metanol 1% de Z. multiflora. Se hizo formulación de Z. multiflora en crema tópica y aplicada por 5-7 días continuos. Los resultados mostraron que el aceite esencial de Z. multiflora (0.1%) puede ser usado de manera segura y eficiente como alternativa en vaginosis bacteriana, candidiasis y en menor grado para tricomoniasis.


Subject(s)
Humans , Female , Adult , Bacterial Infections , Candida albicans , Oils, Volatile , Vaginosis, Bacterial , Calendula , Pruritus , Bacteria , Trichomonas vaginalis , Vaginitis , Yeasts , Candidiasis , Communicable Diseases , Fungi
6.
DST j. bras. doenças sex. transm ; 29(2): 50-53, 20171010.
Article in Portuguese | LILACS | ID: biblio-878928

ABSTRACT

As mais frequentes queixas ginecológicas estão associadas a infecções genitais, que afetam a microbiota vaginal, ou seja, vaginites e vaginoses. A vaginose bacteriana (VB) é caracterizada por uma mudança da microbiota vaginal de bactérias aeróbias para anaeróbias. Já a candidíase vulvovaginal (CVV) é um distúrbio ocasionado pelo crescimento anormal de fungos do tipo leveduras na mucosa do trato genital feminino. Objetivo: Identificar a frequência de VB e Candida sp em exames citológicos (Papanicolaou) em uma cidade no nordeste do Brasil, conforme os meses do ano em um período de quatro anos. Métodos: Estudo de frequência da identificação de VB e Candida sp em exames de citologia oncótica do banco de dados do Laboratório Professor Eleutério em Fortaleza entre os anos de 2012 e 2015. Resultados: Os casos avaliados tinham entre 14 e 54 anos, média de 34,7 anos. Em 2012, o mês de agosto teve maior frequência de VB (62,96%), e o mês de março teve a maior frequência de Candida sp (42,35%). No ano de 2013, VB foi mais prevalente em setembro (61,98%) e Candida sp em agosto (47,26%). Já em 2014, o mês de junho teve maior frequência VB (60,47%), e setembro maior frequência de Candida sp (43,30%). Em 2015, foi abril o mês em que mais se detectou VB (60,30%) e em junho, Candida sp (41,85%). Conclusão: A frequência de VB foi maior que a de Candida sp nos quatro anos. Os meses com maior frequência de patógenos identificados foram os de junho, agosto e setembro, no entanto não houve grandes modificações entre a distribuição durante todo o ano.


The most frequent gynecological complaints are associated with genital infections, which affect the vaginal microbiota, i.e., vaginitis and vaginosis. Bacterial vaginosis (BV) is characterized by a change of the vaginal microbiota from aerobic bacteria to anaerobic bacteria. Vulvovaginal candidiasis (VVC) is a disorder caused by the abnormal growth of yeast type fungi in the mucosa of the female genital tract. Objective: To identify the frequency of BV and Candida sp in Pap (Papanicolaou) smears in a city of Northeastern Brazil, according to the months of the year for a period of four years. Methods: Study of the frequency of the identification of BV and Candida sp in the oncotic cytology tests carried out in the Professor Eleutério Laboratory database in the city of Fortaleza from 2012 to 2015. Results: The average age of the evaluated cases was 34.7 years, varying from 14 to 54 years of age. In 2012, August was the month with a higher frequency of BV (62.96%), and the month of March had the highest frequency of Candida sp (42.35%). In 2013, BV was more prevalent in September (61.98%) and Candida sp in August (47.26%). In 2014, however, the month of June showed most often BV (60.47%) and September had a higher frequency of Candida sp (43.30%). In 2015, it was April the month in which BV was most detected (60.30%), and in June, Candida sp (41.85%). Conclusion: The frequency of bacterial vaginosis was higher than that of Candida sp during four years. The months with the highest frequency of identified pathogens were June, August and September; however, there were no major changes throughout the year.


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Candida/cytology , Seasons , Vaginitis/diagnosis , Vaginosis, Bacterial , Papanicolaou Test
7.
Article in English | WPRIM | ID: wpr-59851

ABSTRACT

BACKGROUND: Next-generation sequencing (NGS) can detect many more microorganisms of a microbiome than traditional methods. This study aimed to analyze the vaginal microbiomes of Korean women by using NGS that included bacteria and other microorganisms. The NGS results were compared with the results of other assays, and NGS was evaluated for its feasibility for predicting vaginitis. METHODS: In total, 89 vaginal swab specimens were collected. Microscopic examinations of Gram staining and microbiological cultures were conducted on 67 specimens. NGS was performed with GS junior system on all of the vaginal specimens for the 16S rRNA, internal transcribed spacer (ITS), and Tvk genes to detect bacteria, fungi, and Trichomonas vaginalis. In addition, DNA probe assays of the Candida spp., Gardnerella vaginalis, and Trichomonas vaginalis were performed. Various predictors of diversity that were obtained from the NGS data were analyzed to predict vaginitis. RESULTS: ITS sequences were obtained in most of the specimens (56.2%). The compositions of the intermediate and vaginitis Nugent score groups were similar to each other but differed from the composition of the normal score group. The fraction of the Lactobacillus spp. showed the highest area under the curve value (0.8559) in ROC curve analysis. The NGS and DNA probe assay results showed good agreement (range, 86.2-89.7%). CONCLUSIONS: Fungi as well as bacteria should be considered for the investigation of vaginal microbiome. The intermediate and vaginitis Nugent score groups were indistinguishable in NGS. NGS is a promising diagnostic tool of the vaginal microbiome and vaginitis, although some problems need to be resolved.


Subject(s)
Area Under Curve , Bacteria/genetics , Bacterial Proteins/genetics , Candida/genetics , Female , Fungal Proteins/genetics , Gardnerella vaginalis/genetics , High-Throughput Nucleotide Sequencing , Humans , Microbiota , RNA, Ribosomal, 16S/chemistry , ROC Curve , Sequence Analysis, DNA , Trichomonas vaginalis/genetics , Vagina/microbiology , Vaginitis/diagnosis
9.
Article in Chinese | WPRIM | ID: wpr-330200

ABSTRACT

Mycotic vaginitis is a common and frequently-occurring gynaecopathia and easy to attack repeatedly, so painful to patients. In this study, the authors observed the clinical efficacy of Sophora gel combined with Fluconazole capsules in treating mycotic vaginitis, in order to seek an effective method for treating mycotic vaginitis. Totally 85 patients with mycotic vaginitis treated in our hospital between December 2012 and July 2014 were randomly divided into the treatment group (43 patients) and the control group (42 patients). The treatment group was given vaginally Sophora gel (one piece every night for 14 days) and orally Fluconazole capsules (150 mg, once every three days, four times in total); The control group was only administered with Fluconazole capsules. The total efficacy, cure rate, recurrence rate and clinical symptom improvements of the two groups were observed. The results show that the total efficacy, the cure rate and the recurrence rate of the treatment group vs. the control group were respectively 97.7%, 90.7% and 2.6% vs. 83.3%, 71.4% and 20.0%, with statistical significance in their differences (P < 0.05). The treatment group showed reduced leucorrhea, pruritus vulvae disappearance and earlier mucosal hyperemia disappearance than the control group, with statistical significance in their differences (P < 0.05). In conclusion Sophora gel combined with Fluconazole capsules can improve antifungal activity of drugs, relieve clinical symptoms, shorten the course of disease, enhance the cure rate and reduce the recurrence rate; So this therapy can be widely applied in clinic.


Subject(s)
Adult , Antifungal Agents , Capsules , Drug Therapy, Combination , Drugs, Chinese Herbal , Female , Fluconazole , Humans , Mycoses , Drug Therapy , Sophora , Chemistry , Treatment Outcome , Vaginitis , Drug Therapy , Young Adult
11.
Article in English | WPRIM | ID: wpr-632605

ABSTRACT

OBJECTIVE: This randomized, single-blind, two-arm controlled study compared the efficacy, safety, and tolerability of an intravaginal suppository preparation containing metronidazole 750mg + miconazole 200mg (Neopenotran Forte) with another vaginal preparation containing metronidazole 500 mg + nystatin 10000 IU (Flagystatin) in the treatment of bacterial vaginosis (BV), candidal and trichomonial vulvovaginitis (CVV, TV), mixed vaginitis and in the prevention of secondary candidal vulvovaginitis. MATERIALS AND METHODS: Women ages 18-45 years with chief complaints of abnormal vaginal discharge or vaginal/vulvar itching were examined and microbiologic confirmation of BV, VVC, TV or mixed infection was made. They were then randomly assigned to receive either treatment once daily (nightly) for 7 days. A total of 261 subjects had evaluable clinical and microbiological findings at the end of the study. Test of cure by Amsel criteria and Nugent score were performed twice after treatment. RESULTS: The overall test revealed that microbiological cure rate is significantly different between the two treatment groups. CONCLUSION: The odds of being cured microbiologically is 2.35 times more in the metronidazole 750mg + miconazole nitrate 200mg group compared to the metronidazole 500 mg + nystatin 10000 IU group. However, no significant difference in the clinical cure between the two groups was found. Both drugs are safe and convenient to use.


Subject(s)
Humans , Female , Adult , Young Adult , Vaginosis, Bacterial , Candidiasis, Vulvovaginal , Suppositories , Vaginitis
12.
Article in English | IMSEAR | ID: sea-157645

ABSTRACT

Vaginitis is among the most common conditions for which women seek medical care, with vaginal discharge accounting for approximately 10 million office visits each year. Since there are no published studies till date that evaluated the Clinical Effectiveness and Safety of Topical Cream of Formula A [Ofloxacin (0.75 % w/w) + Ornidazole (2% w/w) + Terbinafine Hydrochloride (1% w/w) + Clobetasol Propionate (0.05% w/w)] compared to Formula B [Clotrimazole (1%w/w) + Beclometasone Dipropionate (0.025%w/w) + Neomycin Sulphate (0.5% w/w)], Formula C [Clotrimazole (1%w/w) + Beclometasone Dipropionate (0.025%w/w) + Neomycin Sulphate (0.5% w/w)], and Formula D [Clotrimazole (1%w/w) + Beclometasone Dipropionate (0.025%w/w) + Neomycin Sulphate (0.5% w/w)], in mild to moderate vaginitis, hence we undertook this randomized controlled Post Marketing Multicentric trial. Materials and methods: Female subjects diagnosed with mild to moderate symptoms of Vaginitis were eligible and those fulfilling the subject selection criteria were randomized to receive either Formula A, Formula B, Formula C or Formula D for 14 days. The Primary efficacy measures were assessment of symptoms of Vaginitis i.e. vaginal pruritis, vaginal irritation, vaginal soreness or pain, dyspareunia, vaginal erosion and vaginal inflammation and Secondary efficacy measures were assessment of Physical characteristics of vaginal discharge, assessment of pH of vaginal discharge and Microbiological evaluation. Assessment of Safety was done by recording the occurrence of adverse drug reactions. Results: The clinical success rates were comparable and even far better in case of Formula A group (in vaginal pain, Dyspareunia and vaginal erosion it was 100 %, in case of vaginal inflammation it was 92.655 % while in case of vaginal irritation, it was 94.767 % and vaginal pruritus, it was 87.096 %). Adverse events were mild and self limiting while it was totally absent in case of Formula A group. Conclusion: Topical Cream of Formula A is safe and effective for the treatment of mild to moderate vaginitis.


Subject(s)
Adult , Beclomethasone/administration & dosage , Beclomethasone/analogs & derivatives , Clobetasol/administration & dosage , Clotrimazole/administration & dosage , Drug Combinations , Dyspareunia/drug therapy , Dyspareunia/microbiology , Female , Humans , Naphthalenes/administration & dosage , Naphthalenes/analogs & derivatives , Neomycin/analogs & derivatives , Neomycin/administration & dosage , Ofloxacin/administration & dosage , Ornidazole/administration & dosage , Vaginal Diseases/drug therapy , Vaginal Diseases/microbiology , Vaginitis/drug therapy , Vaginitis/microbiology
14.
Laboratory Medicine Online ; : 105-111, 2014.
Article in Korean | WPRIM | ID: wpr-76366

ABSTRACT

BACKGROUND: Infectious vaginitis is a common gynecologic disease that is primarily caused by three pathogens (Trichomonas vaginalis, Gardnerella vaginalis, and Candida species). The aim of this study was to confirm the effects of other infectious vaginitis-related test results on the interpretation of Gram stain and Papanicolaou (Pap) smear test results for disease diagnosis. METHODS: A total of 300 vaginal samples were collected from women presenting symptoms of vaginitis. The presence of the three previously mentioned pathogens was evaluated using both a Gram stain and Pap smear test, and interpreted twice by 4 different observers. The first interpretation was performed without any information, and a second interpretation was performed with knowledge of results of an Affirm VPIII test that was used to diagnose infectious vaginitis. The results from the two interpretations were compared and the sensitivity and specificity of both tests were evaluated. RESULTS: For the Gram stain samples, the detection rates of G. vaginalis were increased in the second interpretation by 6.2%, while the detection rates of Candida spp. were decreased by 0.3%. For the Pap smear test samples, the detection rates of G. vaginalis were increased in the second interpretation by 7.0%, and the detection rates of Candida spp. were increased by 2.0%. The sensitivity of both tests was increased in the second interpretation by 5.5% to 66.7%. There was no difference in the specificity between the two interpretations. CONCLUSIONS: We demonstrated that there is significant inter-observer variation when using Gram stain and Pap smear test results to diagnose infectious vaginitis. The detection rates and sensitivity of both tests changed when the results from an additional test were incorporated into the interpretation. Additional studies are needed to develop objective criteria and a standardized interpretation system for the evaluation of results from these diagnostic tests.


Subject(s)
Candida , Diagnosis , Diagnostic Tests, Routine , Female , Gardnerella vaginalis , Genital Diseases, Female , Humans , Knowledge of Results, Psychological , Observer Variation , Papanicolaou Test , Sensitivity and Specificity , Vaginitis
15.
Article in English | LILACS | ID: lil-754440

ABSTRACT

The influence of vaginal infections on the natural history of human papillomavirus (HPV) is still unclear. Objective: To determine if patientswith low-grade squamous intraepithelial lesions (LSILs) and HPV have more vulvovaginitis than patients with normal liquid-based cervical cytology whowere negative for HPV. Methods: This is a cross-sectional study including 322 patients who underwent cervical exams. One hundred and sixty-seven ofthese patients had LSILs on cervical cytology and were simultaneously hybrid capture 2 (HC2)-positive for HPV, and the remaining 155 patients were negative for malignancies and intraepithelial lesions by cytology and HC2-negative for HPV. The prevalence of vaginal infections in both groups was compared using the X2 test without Yates' correction. Results: Among the patients with HPV and LSILs, the most common vaginal infection was vaginosis(8.98%) compared to candidiasis (12.9%) in the patients without LSILs and HPV. No significant differences were found in the prevalence of vaginosisbetween the two groups (p=0.53). Candidiasis was statistically more prevalent in patients without LSILs and HPV (p<0.001). Conclusion: An associationwas found between the presence of Candida and the absence of HPV. Although vaginosis was more frequent among patients with LSILs and HPV, it wasnot statistically significant.


A influência das infecções vaginais na história natural do papillomavirus humano (HPV) ainda é incerta. Objetivo: Determinar se pacientes com lesões intraepiteliais escamosas de baixo grau (LIEBG) e HPV têm mais vulvovaginites que aquelas com citologia cervical em meio líquido normal e testes negativos para HPV. Métodos: Este é um estudo transversal, que incluiu 322 mulheres que fizeram exames de colo. Cento e sessenta e sete destas tinham LIEBG na citologia oncótica e foram simultaneamente positivas para HPV na captura híbrida 2 (CH2). As outras 155 tiveram citologias negativas para neoplasia intraepitelial e malignidade e eram CH2 negativas para HPV. A prevalência de infecção vaginal nos dois grupos foi comparada usando o teste do X2 sem correção de Yates. Resultados: Entre as pacientes com HPV e LIEBG, a infecção vaginal mais comum foi a vaginose (8,98%), enquantoque, no grupo sem LIEBG e sem HPV, foi a candidíase (12,9%). Nenhuma diferença estatisticamente significante foi encontrada na prevalência de vaginose entre os dois grupos (p=0,53). Candidíase foi estatisticamente mais prevalente nas pacientes sem LIEBG e HPV (p<0,001). Conclusão: Foi encontrada uma associação entre a presença de Candida e a ausência de HPV. Embora a vaginose tenha sido mais frequente em pacientes com LIEBG e HPV, esse dado não foi estatisticamente significante.


Subject(s)
Humans , Female , Adult , Middle Aged , Papillomavirus Infections , Vaginitis , Candida/cytology , Cross-Sectional Studies , Papanicolaou Test
16.
Acta bioquím. clín. latinoam ; 47(3): 551-560, set. 2013. ilus, tab
Article in Spanish | LILACS | ID: lil-694574

ABSTRACT

Disfunción vaginal (DV) (vaginosis/vaginitis) es el síndrome genérico de mayor prevalencia, alcanzando el 50% de todas las mujeres en edad fértil (sintomáticas y asintomáticas). El virus del Papiloma Humano (HPV) se detecta en 30 a 40% de mujeres en edad fértil (sintomáticas y asintomáticas) y se asocia a alteraciones pre-neoplásicas y a carcinoma invasor del cuello uterino. El diagnóstico sindrómico de DV y alteraciones inducidas por HPV es ineficiente y en la actualidad la morfología (macro y microscópica) es el gold standard, pero requiere ordenamiento. El Estudio del Contenido Vaginal es la prueba de laboratorio bacteriológico de mayor solicitud luego del urocultivo. BACOVA normatiza el diagnóstico de vaginosis/vaginitis y ERIGE aumenta el valor predictivo de células que alertan sobre alteraciones epiteliales. Desde 2007 al presente en los talleres BACOVA ERIGE (tinción de Giemsa) se evaluó la sensibilidad de la detección de células anormales exfoliadas. Un 99% de los participantes coincidió con la detección de koi-locitos. BACOVA/ERIGE no reemplaza al Papanicolaou de ninguna manera, pero puede y debe realizarse en laboratorios periféricos, con lo que además del diagnóstico de vaginosis/vaginitis con 100% de valor predictivo, aumentan la cobertura preventiva de estados proliferativos.


Vaginal dysfunction (DV) (vaginosis/vaginitis) is the generic syndrome of major prevalence, reaching 50% of all women in fertile age (symptomatic and asymptomatic). The Human Papillomavirus (HPV) is detected in 30-40% of women in fertile age (symptomatic and asymptomatic) and is associated to pre-neoplastic lesions and invading carcinoma of the uterine cervix. The diagnosis for the symptoms of DV and the alterations induced by HPV are inefficient and at present, the morphology (macroscopic and microscopic) is the standard gold, but it needs better classification. The Study of the Vaginal Content is the test of major request after urocultives in bacteriological laboratories. BACOVA establishes the procedure for the diagnosis of vaginosis/vaginitis and ERIGE increases the predictive value of cells that give the alarm on epithelial alterations. From 2007 to the present sensitivity in the detection of abnormal exfoliated cells from vagina and uterine cervix was evaluated during the BACOVA - ERIGE, (Giemsa's stain) workshops, 99% of the participants coincided with the detection of koilocytes. BACOVA/ERIGE does not replace the Papanicolaou by any means, but it can and must be performed in peripheral laboratories, where apart from the diagnosis of vaginosis/vaginitis with 100% of predictive value, it is possible to increase the detection of precocious proliferative changes of the squamous epithelium.


Disfungào vaginal (DV) (vaginose / vaginite) é a síndrome mais prevalente genérica, atingindo 50% de todas as mulheres em idade fértil (sintomáticas e assintomáticas). O Papilomavírus Humano (HPV) é detectado em 30-40% das mulheres em idade fértil (sintomáticas e assintomáticas) e está associado a alteragòes pré-neoplásicas e a carcinoma invasivo do colo do útero. O diagnóstico sindrómico de DV e alteragòes induzidas pelo HPV é ineficiente e atualmente a morfologia (macroscópica e microscópica) é o padrào ouro, mas precisa de ordenamento. O Estudo do Conteúdo Vaginal é o exame de laboratòrio bacteriológico mais solicitado, seguido da urocultura. BACOVA normatiza o diagnòstico de vaginose/ vaginite e ERIGE aumenta o valor preditivo de células que alertam a respeito de alteragòes epiteliais. Desde 2007 até hoje, nos workshops BACOVA/ERIGE (coloragào de Giemsa), foi avaliada a sensibili-dade da detecgào de células anormais esfoliadas. 99% dos participantes coincidiram com a detecgào de coilócitos. Bacova/Erige nào substitui o Papanicolaou de forma alguma, mas pode e deve ser feito em laboratórios periféricos, com o qual além do diagnóstico de vaginose / vaginite com 100% de valor preditivo, aumentam a cobertura preventiva de estados proliferativos.


Subject(s)
Humans , Female , Papillomaviridae , Papillomavirus Infections/diagnosis , Uterine Cervical Neoplasms , Alphapapillomavirus , Azure Stains , Gammapapillomavirus , Mupapillomavirus , Reference Values , Vaginitis
17.
Rev. costarric. salud pública ; 22(1): 56-60, ene.-jun. 2013. ilus, graf, tab
Article in Spanish | LILACS | ID: lil-684394

ABSTRACT

Las infecciones vaginales representan uno de los problemas ginecológicos más comunes en mujeres en edad reproductiva. Objetivo: Clasificar la leucorrea fisiológica y patológica de las pacientes investigadas, además de analizar si esta última obedece a infecciones cervico-vaginales. Método: La presente investigación se realizó a población abierta de todas las pacientes que acudieron al laboratorio de biología celular de la Benemérita Universidad Autónoma de Puebla al programa de detección oportuna de cáncer (Papanicolaou) desde enero del 2001 a Diciembre 2012, en las que se obtuvo un total de 1 679 muestras vaginales mismas que fueron teñidas con el tren de tinción de Papanicolaou modificado para su posterior diagnóstico microscópico. Resultados: Se encontró que 923 fueron positivas a leucorrea, de las cuales 489 corresponden a leucorrea fisiológica, 285 leucorrea patológica y las 149 no se ubican en ningún grupo. Discusión: Las infecciones cervico-vaginales se pueden presentar como respuesta a la presencia polimicrobiana que coloniza la cavidad vaginal y que esto conlleva un conjunto de signos y síntomas no específicos de los agentes que las causen, entre los que se encuentra la leucorrea como dato clínico que motiva en muchos casos a la consulta ginecológica. De las infecciones cervico-vaginales, la vaginitis es la causa más común de descarga vaginal patológica o leucorrea seguida de la cervicitis siendo ambas causadas por diversos agentes y de los que se mencionan los más frecuentes.


Vaginal infections are one of the most common gynecological problems in women of reproductive age. Objective: To classify physiological and pathological leucorrhoea in patients investigated, in addition to analyzing whether the latter is due to cervico-vaginal infections. Methods: This research was performed with an open population of all patients who came to the cancer screening program (Pap) at the Cell Biology Laboratory of the Benemérita Universidad Autónoma de Puebla from January 2001 to December 2012, where 1 679 vaginal samples were stained with the Papanicolaou stain set, modified for subsequent microscopic diagnosis. Results: Nine hundred twenty three were found to be positive for leucorrhea; of which 489 correspond to physiological leucorrhea and 285 to pathological leucorrhea; 149 are not located in any group. Discussion: Cervico-vaginal infections may occur in response to polymicrobial presence which colonizes the vaginal cavity; and this entails a set of signs and symptoms produced by nonspecific agents, among which is leucorrhoea as a clinical manifestation that motivates, in many case, a gynecological consultation. Among cervicovaginal infections, vaginitis is the most common cause of pathological vaginal discharge or leucorrhoea; followed by cervicitis; both of which are caused by various agents, of which we mention here those most frequently found.


Subject(s)
Humans , Female , Vaginitis , Uterine Cervicitis , Papanicolaou Test , Leukorrhea/diagnosis , Leukorrhea/pathology , Mexico
18.
Razi Journal of Medical Sciences. 2013; 19 (104): 60-66
in Persian | IMEMR | ID: emr-127187

ABSTRACT

Nystatin is a polyene with antifungal effect which is used in treatment of cutaneous and mucocutaneous candidiasis in diverse forms. Increasing its utilization in recent years has led to predominant increasing of resistances. Nowadays for increasing of antifungal effect and decreasing of resistance and side effects of drugs they are used in combination with each other. So we decided to investigate antifungal effect of Nystatin in combination with nanosilver particles. This was an experimental study which has been accomplished on 30 samples of isolated candida species from patients effected to chronic candidal vaginitis. In this study the antifungal effects of Nystatin and silver nanoparticles each of them alone and in combination with each other by microdilution broth, were examined. Findings were described on the base of logestic regression and man-vitni exam. Findings suggested that Nystatin was able to inhibit the growth of candida species at an expanded range of concentration between 16-128 microgeram per milliliter. As well antifungal activity of Nystatin with silver nanoparticles was increased in comparision with using Nystatin alone. Introduce of nanosilver in drug formation of Nystatin can be useful in treatment of chronic vaginal candidiasis


Subject(s)
Humans , Female , Nystatin , Silver , Nanoparticles , Candidiasis, Vulvovaginal , Vaginitis , Chronic Disease , Antifungal Agents , Drug Combinations
19.
Article in Chinese | WPRIM | ID: wpr-287486

ABSTRACT

<p><b>OBJECTIVE</b>To observe antisepsis, anti-swelling, and therapeutic effects of Fuxiye (FXY), a Chinese medical lotion for external wash in treating vaginitis model rats.</p><p><b>METHODS</b>The cervicitis rat model was induced by agar plate diffusion, ear auricle swelling induced by dimethylbenzene, and chemical stimulus. The in vitro antibiotic actions of FXY were observed. Besides, its effects on the swelling and inflammation in model rats were also observed.</p><p><b>RESULTS</b>FXY at 25 mg/mL could completely inhibit the growth of Pseudomonas aeruginosa, Escherichia coli, pyogenic Streptococcus, and Streptococcus agalactiae. FXY at 50 mg/mL could completely inhibit the growth of Staphylococcus aureus and Candida albicans. It obviously restrained dimethylbenzene induced ear auricle swelling. It significantly alleviated cervicitis induced by chemical stiumli.</p><p><b>CONCLUSION</b>FXY showed better effects on antisepsis, anti-inflammation, and treating cervicitis.</p>


Subject(s)
Animals , Anti-Infective Agents , Pharmacology , Anti-Inflammatory Agents , Pharmacology , Dosage Forms , Drugs, Chinese Herbal , Pharmacology , Female , Rats , Rats, Sprague-Dawley , Uterine Cervicitis , Drug Therapy , Vaginitis , Drug Therapy
20.
Article in Korean | WPRIM | ID: wpr-77182

ABSTRACT

PURPOSE: The study was done to survey feminine hygiene and vaginal douche practices in middle-aged women to obtain basic information for public health education. METHODS: With a descriptive survey design, 134 middle-aged women who have menstrual period were recruited via convenience sampling. Survey contents were from the study by Czerwinski (2000) regarding feminine hygiene and vaginal douching practices. After obtaining IRB approval, a self-administered structured questionnaire was distributed to study participants. RESULTS: Mean age of middle-aged women was 46.88 years old. Fifty-six percent of the women practiced vaginal douching. Women performed douching with water (68%), commercial products (13%), soap (12%), and vinegar-mixed water (6%) for clean and fresh feeling, removal of unpleasant odor, and removal of vaginal discharge. Vaginal douche practice was significantly related to a history of vaginitis. CONCLUSION: The study results indicate that most of the women practiced inadequate feminine hygiene especially in douching, suggesting that is important to develop education programs on feminine hygiene practices for women of all ages, especially regarding douching and hand washing before and after changing pads or tampons.


Subject(s)
Education , Ethics Committees, Research , Female , Hand Disinfection , Humans , Hygiene , Menstruation , Odorants , Public Health , Surveys and Questionnaires , Soaps , Therapeutic Irrigation , Vaginal Discharge , Vaginal Douching , Vaginitis , Water
SELECTION OF CITATIONS
SEARCH DETAIL